<SEC-DOCUMENT>0001193125-25-200197.txt : 20250910
<SEC-HEADER>0001193125-25-200197.hdr.sgml : 20250910
<ACCEPTANCE-DATETIME>20250910171933
ACCESSION NUMBER:		0001193125-25-200197
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20250910
DATE AS OF CHANGE:		20250910

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VERINT SYSTEMS INC
		CENTRAL INDEX KEY:			0001166388
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		ORGANIZATION NAME:           	06 Technology
		EIN:				113200514
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34807
		FILM NUMBER:		251306619

	BUSINESS ADDRESS:	
		STREET 1:		225 BROADHOLLOW ROAD
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6319629600

	MAIL ADDRESS:	
		STREET 1:		225 BROADHOLLOW ROAD
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d947030ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy
Statement Pursuant to Section&nbsp;14(a) of the </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant&#8194;&#9745; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other
than the Registrant&#8194;&#9744; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9745;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material under <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>VERINT SYSTEMS INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9745;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following contains frequently asked questions and answers relating to compensation and benefits
provided to employees of Verint Systems Inc. on September&nbsp;10, 2025. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053930798.jpg" ALT="LOGO" STYLE="width:8.60556in;height:1.01806in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>September&nbsp;10, 2025 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>All Employee FAQ &#8211; Compensation and Benefits </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of Verint<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP><SUP STYLE="font-size:75%; vertical-align:top"> </SUP>signing a definitive
agreement to be acquired by Thoma Bravo, you may have questions about how this acquisition will affect you, in particular as it relates to Compensation and Benefits. Below is a series of questions and answers related to Compensation and Benefits to
help address many of the initial questions you may have. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please note the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any contract you have with Verint governing your employment rights and entitlements will be honored in accordance
with its terms. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All laws applicable to your employment rights and entitlements will be followed. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">This FAQ is meant to provide information regarding your Compensation and Benefits: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Between signing and closing. (Remember, while closing could occur in a few months, it could also take over a
year.) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In cases where Verint and Thoma Bravo have reached agreement about your Compensation and Benefits beyond closing.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please direct any further questions to your HR Business Partner (HRBP). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&#8195;*&#8195;*&#8195;*&#8195;* </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Compensation </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q1: Will there be
changes to my cash compensation or my benefits? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For the remainder of this fiscal year, your base compensation and annual bonus program (whether you are on a
target or discretionary bonus) will remain the same. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Thoma Bravo has agreed that, through at least December&nbsp;31, 2026, employees will continue to earn at least
the same annual cash based compensation as they earned historically. As a result, cash based employee compensation will<B> </B>not be negatively impacted by the merger. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If closing has not occurred by May&nbsp;1, 2026, we will undertake our usual compensation process for our general
employee population. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q2: Does this impact my bonus for the rest of the year? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Your annual bonus plan for FYE26 will not change. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q3: Will my years of service with Verint be credited? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You will be credited with your seniority service for your PTO accruals, and you will be credited with the period
you were employed by Verint for any benefit for which service duration is relevant. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943392.jpg" ALT="LOGO" STYLE="width:0.243056in;height:0.222222in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&copy; 2025 Verint Systems Inc. All Rights Reserved Worldwide. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943298.jpg" ALT="LOGO" STYLE="width:1.85972in;height:0.360417in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q4: Can I continue to work hybrid or remotely? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If you are currently working in a hybrid or remote capacity, you can expect to continue working in that way at
least until December&nbsp;31, 2026. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If there are any changes to our remote work policy in the future, we will communicate them to you well in
advance. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q5: If my position is eliminated, will I receive severance? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Yes, if you are eligible for severance and your position is eliminated on or prior to December&nbsp;31, 2026, you
would be entitled to severance in accordance with Verint&#8217;s Severance Policy if in the U.S., or Verint&#8217;s standard practices outside of the US., if terminated without cause. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If there are any changes to our severance policy, we will communicate them to you well in advance.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Equity </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q1: What happens to my equity? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">At closing, your vested equity awards will be cashed out at the deal price. The cash for these shares will be
deposited directly into the brokerage account where you hold the shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">At closing, your unvested equity awards will be converted to unvested cash-settled awards. The amount of this new
cash-settled award will be equal to the number of unvested shares you hold multiplied by the deal price of $20.50. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">These cash-settled awards will continue to vest on the same schedule as your restricted stock units (RSUs) did
before closing. On each vesting, you will automatically receive a cash payment via payroll equal to the value of the portion of the cash award vesting on that date. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q2: What will happen to my unvested equity if I am terminated without cause after closing? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The unvested outstanding cash-settled awards you receive at closing will accelerate, if you are terminated
without cause (including the elimination of your position), within two years following the closing date. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q3: What happens to my
equity between now and closing? Can I still trade my stock in the company before the closing? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Between signing and closing, your existing equity awards will continue to vest and settle on their regular
schedule. If you are on Verint&#8217;s trading blackout list, you will not be able to sell your shares when they vest and will instead need to hold those vested shares until the transaction closes (unless the blackout is released for whatever
reason). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If you are not on Verint&#8217;s trading blackout list and you are not in possession of material <FONT
STYLE="white-space:nowrap">non-public</FONT> information, you will be able to sell those vested shares if you like. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q4: Will there
be an equity component to my compensation review next year? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If closing hasn&#8217;t occurred by May&nbsp;1, 2026, Verint is permitted to conduct its annual equity process.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943392.jpg" ALT="LOGO" STYLE="width:0.243056in;height:0.222222in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&copy; 2025 Verint Systems Inc. All Rights Reserved Worldwide. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943298.jpg" ALT="LOGO" STYLE="width:1.85972in;height:0.360417in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Following the closing, Thoma Bravo will implement its customary, broad-based incentive equity program like it
does at all of its portfolio companies. Thoma Bravo is working with the leadership team during the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sign-to-close</FONT></FONT> period to design this program and communicate it to
employees given that incentive plans are a critical part of the way Thoma Bravo works with the colleagues at the companies it invests into. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>U.S.-Only Questions Below </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Benefits </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q1: What will happen
to my employee health benefits? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">As noted above, your current benefits (including medical benefit programs) will remain unchanged through
December&nbsp;31, 2026, whether or not the closing has occurred. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If there are any changes to our benefits, we will communicate them to you well in advance. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q2: What happens to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">deductibles/out-of-pocket</FONT></FONT> maximums I paid, if
benefit plans are changed <FONT STYLE="white-space:nowrap">mid-year?</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Although we do not expect this to occur, should plans change <FONT STYLE="white-space:nowrap">mid-year,</FONT> we
will work with the carriers to bring over <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> maximums and deductibles to the new plans for any monies paid within the plan year, so you do not have to restart
your deductible and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> limits. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q3: What
will happen to my FSA and Dependent Care accounts? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For 2025 and 2026, there will be no change to your FSA or Dependent Care accounts. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If there are any changes to FSA and Dependent Care options, we will communicate them to you well in advance.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q4: Will U.S. employees be able to change their benefit elections for 2026? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Yes, Verint will host Open Enrollment from October 8<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>
through October 22<SUP STYLE="font-size:75%; vertical-align:top">nd</SUP>, when you will be able make your benefit elections, update dependents, reenroll in your FSA and Dependent Care accounts and/or switch your healthcare plan options for the 2026
plan year. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q5: What will happen to my PTO? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Your current PTO program will remain in place through December&nbsp;31, 2026. You will continue to be eligible
for your specific carry-over and donation options available to you today and accrue under the current service seniority you have today. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If there are any changes to our PTO policy, we will communicate them to you well in advance.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>401(K) Savings Plan </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q1: What will happen to my 401(k) benefits? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Your current 401(k) benefits will remain the same through closing, at which time we will review options available
to the combined companies and provide timely communication for decisions made. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943392.jpg" ALT="LOGO" STYLE="width:0.243056in;height:0.222222in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&copy; 2025 Verint Systems Inc. All Rights Reserved Worldwide. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943298.jpg" ALT="LOGO" STYLE="width:1.85972in;height:0.360417in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Q2: Will I receive my 401(k) company match, if I am eligible? </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Yes, eligible employees will receive their company match. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains
and the other filings and press releases of Verint Systems Inc. may contain forward-looking statements, which include all statements that do not relate solely to historical or current facts, such as statements regarding our expectations, intentions
or strategies regarding the future. In some cases, you can identify forward-looking statements by the following words: &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221;
&#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;aim,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221;
&#8220;ongoing,&#8221; &#8220;goal,&#8221; &#8220;can,&#8221; &#8220;seek,&#8221; &#8220;target&#8221; or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. These forward-
looking statements are based on management&#8217;s current beliefs, as well as assumptions made by, and information currently available to, Verint, all of which are subject to change. Because such statements are based on expectations as to future
financial and operating results and are not statements of fact, actual results may differ materially from those projected and are subject to a number of known and unknown risks and uncertainties, including: (i)&nbsp;the risk that the proposed
transaction may not be completed in a timely manner or at all, which may adversely affect Verint&#8217;s business and the price of its common stock; (ii)&nbsp;the failure to satisfy any of the conditions to the consummation of the proposed
transaction, including the receipt of certain regulatory approvals; (iii)&nbsp;the failure to obtain stockholder approval of the proposed transaction; (iv)&nbsp;the occurrence of any fact, event, change, development or circumstance that could give
rise to the termination of the transaction agreement, including in circumstances requiring Verint to pay a termination fee; (v)&nbsp;the effect of the announcement or pendency of the proposed transaction on Verint&#8217;s business relationships,
operating results and business generally; (vi)&nbsp;risks that the proposed transaction disrupts Verint&#8217;s current plans and operations; (vii)&nbsp;Verint&#8217;s ability to retain and hire key personnel and maintain relationships with key
business partners and customers, and others with whom it does business, in light of the proposed transaction; (viii)&nbsp;risks related to the diversion of management&#8217;s attention from Verint&#8217;s ongoing business operations;
(ix)&nbsp;unexpected costs, charges or expenses resulting from the proposed transaction; (x)&nbsp;the ability of Calabrio to obtain financing for the proposed transaction; (xi)&nbsp;potential litigation relating to the proposed transaction that
could be instituted against the parties to the transaction agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto; (xii)&nbsp;continued availability of capital and financing and rating
agency actions; (xiii)&nbsp;certain restrictions during the pendency of the proposed transaction that may impact Verint&#8217;s ability to pursue certain business opportunities or strategic transactions; and (xiv)&nbsp;other risks described in
Verint&#8217;s filings with the SEC, such risks and uncertainties described under the headings &#8220;Forward-Looking Statements,&#8221; &#8220;Risk Factors&#8221; and other sections of Verint&#8217;s Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> filed with the SEC on March&nbsp;26, 2025 and subsequent filings. No list or discussion of risks or uncertainties should be considered a complete statement of all potential risks and uncertainties. Unlisted or
unknown factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among
other things, business disruption, operational problems, financial loss, and legal liability to third parties and similar risks, any of which could have a material adverse effect on the completion of the proposed transaction and/or Verint&#8217;s
consolidated financial condition, results of operations, credit rating or liquidity. The forward-looking statements speak only as of the date they are made. Verint undertakes no obligation to provide revisions or updates to any forward-looking
statements, whether as a result of new information, future events or otherwise, should circumstances change, except as otherwise required by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943392.jpg" ALT="LOGO" STYLE="width:0.243056in;height:0.222222in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&copy; 2025 Verint Systems Inc. All Rights Reserved Worldwide. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943298.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information and Where to Find It </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication may be deemed to be solicitation material in respect of the transaction between Verint Systems Inc., Calabrio Inc. and Viking Merger Sub,
Inc. Verint expects to announce a special meeting of stockholders as soon as practicable to obtain stockholder approval of the proposed transaction. In connection with the transaction, Verint intends to file relevant materials with the SEC,
including a proxy statement in preliminary and definitive form. INVESTORS ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL
CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTION AND THE PARTIES TO THE TRANSACTION. Investors may obtain a free copy of these materials (when they are available) and other documents filed by Verint with the SEC at the SEC&#8217;s website at
www.sec.gov, at Verint&#8217;s website at www.verint.com or by sending a written request to Verint in care of the Corporate Secretary, at Verint Systems Inc., 225 Broadhollow Road, Melville, New York 11747. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in the Solicitation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The directors and
executive officers of Verint, and other persons, may be deemed to be participants in the solicitation of proxies in respect of the transaction. Information regarding Verint&#8217;s directors and executive officers is available in Verint&#8217;s
definitive proxy statement filed with the SEC on May&nbsp;8, 2025 in connection with Verint&#8217;s 2025 annual meeting of stockholders. This document can be obtained free of charge from the sources indicated above. Other information regarding
persons who may be deemed participants in the solicitation of proxies and a description of their interests, by security holdings or otherwise, will be included in the proxy statement relating to the transaction (when available) and other relevant
materials to be filed with the SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g947030g0910053943392.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&copy; 2025 Verint Systems Inc. All Rights Reserved Worldwide. </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g947030g0910053930798.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g947030g0910053930798.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !@ RX# 2(  A$! Q$!_\0
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MVD,!NV]J<N_9Q30&V\4Y=^S@TT @W[:%+[.U #;.*!NV\&E< &[;Q0H;9VH
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ME+^5@-@>E-&[9UH$K]15+^7@'BD&[9UXH ;9UI51C'G/'I1N/8 K>7D'CTI
M&V=:!N\O@\>E #;.O% " -LZT '9UI0IV9S2 '9UI  !V=:,-LX- #;.M #;
M.M !SLZT#=LZTH4[.M 4[,YH&-P=G6G -LZTF#LZTHW;.M" 0 [>M #;>M !
MV]:4*=G6@! &V=: &V=: &V=: &V=:  !MG6@!MG6@ [.M !V=:!  VV@ [.
MM&&V=: #LZT  !V=:4*WE\&DP=G6E&[9UXH 0!MO6E7=CK2 -LZTJ@[1SB@!
MR@[>#2*#BE&<=:09QUIB!0<=: #CK0H..M !QUH %!Q0 =N,T*#CK0H.WK2
M^AOA!KBZUX+;2[A@\MB3"RGO$?N_U'X5IW:V?PU^'5T+4C]P',1/5Y'8[?YC
M\J\3^'/BM/"7B3[7<ES931&.=4&3Z@X]C_.MKXF_$"U\76]E9Z695M(F,LOF
M+MW/T'Y<UQ2H2=2W1FRFN4\Y+22,\CN6=V+,3W)ZUZM\!O\ D/ZM_P!>J_\
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MU0=G6D)7Z@ =O6GI$QBR&_"F*I*=:<N[R\!L#TIH'?H- ;9UH ;9UH .SK0
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MFE6-O+R&_"F@'9UXI1N\O&[CTIH! #LZTY8R8LY]\4T [.M. ;ROO<>E" :
M=G6@ [.M !\OK0 =G6D  '9UI5!VCFD .SK2JIVCG% #E!QUH4';P:%!*]<4
M*/EZTQ H.WK0H..M !QUH4$CK0 *#CK0H.WK0JG;UH4';UH 10=O6A0=O6A0
M=O6A0=O6@ 4';UH4$KP:%!V\&E53MZXH 0 [>M !V]<4*#MZT $KUI  !*]:
M%!V]:55)7K2 ':><4P!0=O6E4':>:%!VGFA5.WK0,%4E>M(H)4\TJJ=O6D53
MMZT *JG;U(I%!P>:%!V]:%4X/-  JG!YH4''6E524/-"J2IYH 15)4\T*"5/
M-"@[3S2JI*]<9H 102I.:%4[>M"@[>M !V]>M( 525ZT*I*]<4*#MX-"@E>M
M,! #MZTJ@[/O$4*"5ZT*I*]:0 H.W@XI%!VY!J:* O%NWD9Z"HE4[>N*8DT]
MA50E,[L4U5.W(-.53M^]^%"J2OWL4#&JI*YR:%!V?>H4';PQ%"@E?O&D JAM
MO7%( =O7%"@E>M 4E>M%@!0=O7%*H.S[U*L9,>=V,U)%;EH=V_&>@%.PFTMR
M$*=O6E53MZT*IV]:%4[/O8I6&"J=IYI &V_>H4';UQ[4*OR]:  *=O6@!MG#
M8H .WK^% 4[3S0 !3MZTJJ2O7\*0*=G6GI$3'G<?I32!NPP*=IYJ>*U+P%]^
M">@J%4)3[Q%.3S/+($A"GM2L U=P0C<1[4@4[.M*J$I]ZE5"8\[OPIV %C)C
MSN_"F@';UI5W;.&('I2!3LZX]J 0 '9UQ0 =O6@ [>M !V]:0  =G6G(C&/[
MV/:D5"4SNI%#;/O'Z4T  ';UH5"4ZTH4[,YI #LX)I  4[.M*JMY?#$>U(%.
MWK0 =G6A *J'R\YQ30"4ZTY5/E_>Z]J:%.SK3 50=G4TJH?+ZT*A*9W4B@[/
MO'Z4  4E/O4!3L^\:55.S[WX4@!V=: %56,7WOPI IV9R:55;R\[B/:D .SK
M0!(D),.[?CCI3%0E.M*JOY7#D#TIJJ=GWC]*!*XH#>7]X@>E"H3'G=3TA)AS
MOQQTJ-5;9][\* 33V%5"8\[L9J:.U+VV_P S&1G%0 -Y?WC]*<ID\HJ)"%/:
MD,:%.SK0 =G7\*<L9,>=WX4P*=G6G8!0IV=: IV=:0 [.OX4 ';U_"D H!V=
M:58R8L[OPI IV=:4 ^7]X_2A - .SK0 =G6E"DIUI IV]: % .SK^% W>7C<
M<>E( =G6C!V]:8"@'9P?PI IV=:4*=GWJ0 E.M(!06\O ;CTI,'9UI0#LZTF
M#LZT &#LZTN#LZT@4[.M 4[>OX4 3I:%K;S-^"1D"H #LSFE#2>5M#D*>U(
M=G7\*  *=G6G!"8\[OPIH!V=:4!MGWOPH0 %.S.?PI #LZ_A0 ?+ZT!3LZT
G !V=: IV=: #LZ_A2A3LZT ( =G6E53M!W4!3LZT(#M&&(H0'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g947030g0910053943298.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g947030g0910053943298.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  B + # 2(  A$! Q$!_\0
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MW%*TEN>#^)_^1UU#_K\_J*]\'W5^E>!^)O\ D==1_P"OS^HKWP'Y5^E5F_\
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F8X69LQH@"G/7@59TF*.&Q18HT1222%4#)S1117^.7J*AM'T/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g947030g0910053943392.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g947030g0910053943392.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  5 !<# 2(  A$! Q$!_\0
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6;?\ +-9>E%%"!G: 8X'04444AG__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
